Skip to main content

DaVita Agrees To Pay $383.5 Million in A Wrongful Death Case

DaVita Agrees To Pay $383.5 Million in A Wrongful Death Case

DaVita Agrees To Pay $383.5 Million in A Wrongful Death Case

Introduction

One of the largest dialysis providers, DaVita Inc., recently agreed to pay $383.5 million to the families of three patients who died of cardiac arrest following dialysis treatment at DaVita's. The Denver-based company was ordered to compensate for the wrongful death by a Denver jury in June 2018. The compensation included $125 million in punitive and $1.5 million to $5 million in compensatory damages.

DaVita was blamed in the lawsuit filed by the families for not forewarning about the health risks of GranuFlo treatment which caused toxic pH imbalances and alkalosis in the patients. Attorneys representing the plaintiffs asserted that the dialysis provider was aware of the toxicity of the product. Granuflo lawsuits were centralized in the District of Massachusetts as a multidistrict litigation in 2013 (MDL No. 2428; In Re: Fresenius GranuFlo/NaturaLyte Dialysate Litigation) before Judge Douglas P. Woodlock.

Comments

HELLO I'M LOOKING FOR AN ATTORNEY FOR DEATH MY MOM JUST DIED 3/24/25 FROM AN INFECTED CATHER CAUSING A STAPHY INFECTION SPREAD THROUGHOUT THE BODY. FROM DAVITA DIAYSIS NOT PROPERLY CLEANING IT REGULARLY OR REPLACEMENTS. AFTER DIAYSIS FRIDAY WENT WEAK CHECKED INTO ER DIED MARCH 24 2025 OF INFECTION FROM CATHER

-
NADINE MONELAVONGSY

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Cencora Directors Settle Opioid Oversight Case for $111M

Categories: Opioids

Cencora has agreed to pay $111.3 million to settle a shareholder lawsuit accusing the company’s directors of failing to prevent the unlawful distribution of opioids

Study Finds CPAP May Harm Low-Risk Sleep Apnea Patients

A new study has cast doubt on the long-standing belief that continuous positive airway pressure (CPAP) machines significantly reduce heart…

FDA Adds New Warnings on Long-Term Opioid Risks

Categories: Opioids

Federal regulators have raised concerns that many opioid medications were approved for prolonged use without sufficient clinical evidence confirming their safety.

✍️ FREE — 2,800 Pages Legal Process Outsourcing Trial!                 
No Contract. No Risk — Full Mass Tort + LPO Access, Free!

Only 10 Firms Accepted—Offer Ends August 31!